Clinical trial

Sorafenib and Thoracic Radiation for Patients With Non-Small Cell Lung Cancer

NCT00543335

Study summary

ClinicalTrials.gov

Sorafenib and Thoracic Radiation for Patients With Non-Small Cell Lung Cancer

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Sorafenib Normalized identity: sorafenib View linked drug · Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Radiation Therapy Find medicine records · Find other trials using this name

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2008-01-25

PhasePHASE1

Conditions

Lung Cancerverified · MONDO: lung cancer

Interventions

SorafenibDRUG · verified · RxNorm: sorafenib

Radiation TherapyPROCEDURE

Sponsors & collaborators

M.D. Anderson Cancer Centerlead sponsor

Bayercollaborator

Mapped research locations

HoustonTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00543335 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.